PharmChem, Inc.
PCHM · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.2% | 3% | -6.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 63.7% | 64.9% | 64.2% | 62.5% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 28.6% | 17.5% | 19% | 26.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 22.7% | 14.1% | 14.9% | 29.8% |
| EPS Diluted | 0.3 | 0.17 | 0.16 | 0.28 |
| % Growth | 76.5% | 6.3% | -42.9% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |